Diet

Resource Center

FDA Alerts

FDA Alert

Tirzepatide Gains FDA Approval for Chronic Weight Management

11/13/2023

Tirzepatide is now approved for a new indication. The dual GIP/GLP-1 agonist was previously approved for treating type 2 diabetes in May 2022.

11/13/2023

Research Summaries

Research summary

Coconut Water May Help Patients With Mild, Moderate UC Induce Remission

04/16/2024

Jessica Ganga

A team of researchers investigated the use of coconut water as an adjunct therapy for patients with mild-to-moderate ulcerative colitis.

04/16/2024

Research Summary

People With HIV Starting Antiretroviral Therapy Gain Excess Weight in First 2 Years

03/11/2024

Anthony Calabro, MA

Researchers compared people with HIV initiating antiretroviral therapy (ART) with demographically matched people who do not have HIV and did not receive ART to determine whether HIV-specific factors, such...

03/11/2024

Research Summary

Individuals in the United States Are Not Achieving Optimal Vitamin D Levels

02/28/2024

Jessica Ganga

Researchers found that the current recommendations for vitamin D intake in individuals are not enough for patients to reach optimal vitamin D levels.

02/28/2024

Research Summary

Semaglutide Provides Benefits for Patients With HFpEF and Obesity

11/22/2023

Anthony Calabro, MA

Researchers compared the effects of once-weekly semaglutide (2.4 mg) with a placebo during a 52-week period in patients with HFpEF and a BMI of 30 or higher.

11/22/2023

FDA Alert

Tirzepatide Gains FDA Approval for Chronic Weight Management

11/13/2023

Tirzepatide is now approved for a new indication. The dual GIP/GLP-1 agonist was previously approved for treating type 2 diabetes in May 2022.

11/13/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4